Cellyan Biotechnology Co annual ebitda
2023
2024
2025
2026
Cellyan Biotechnology Co EBITDA Growth & History (HKPD)
Cellyan Biotechnology Co's calculated EBITDA was −$307,331 for fiscal 2026.
View full Cellyan Biotechnology Co company overviewCellyan Biotechnology Co annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | −$307,331 | $1.9M | — |
| 2025 | 2025-03-31 | −$2.2M | −$322,289 | — |
| 2024 | 2024-03-31 | −$1.9M | −$178,832 | — |
| 2023 | 2023-03-31 | −$1.7M | — | — |
Cellyan Biotechnology Co ebitda trends
Between the periods ended 2023-03-31 and 2026-03-31, Cellyan Biotechnology Co's ebitda increased from −$1.7M to −$307,331, a change of $1.4M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cellyan Biotechnology Co source filings ↗